Medicines (Mar 2024)

Improved Outcomes in Eosinophilic Esophagitis with Higher Medication Possession Ratio

  • Nathan T. Kolasinski,
  • Eric A. Pasman,
  • Cade M. Nylund,
  • Patrick T. Reeves,
  • Daniel I. Brooks,
  • Katerina G. Lescouflair,
  • Steve B. Min

DOI
https://doi.org/10.3390/medicines11040008
Journal volume & issue
Vol. 11, no. 4
p. 8

Abstract

Read online

Eosinophilic esophagitis (EoE) disease activity can be caused by treatment non-adherence. Medication possession ratio (MPR) is an established metric of medication adherence. A higher MPR correlates with better outcomes in several chronic diseases, but MPR has not been investigated with respect to EoE. A retrospective cohort study was performed using an established EoE registry for the years 2005 to 2020. Treatment periods were identified, MPRs were calculated, and medical records were assessed for histologic remission (p < 0.001). The optimal MPR cut-point for histologic remission was 0.7 (Sen 0.66, Spec 0.62, AUC 0.63). With MPRs ≥ 0.7, there were significantly increased odds of histologic remission (odds ratio 3.05, 95% confidence interval 1.79–5.30) and significantly decreased odds of dysphagia (OR 0.27, 95% CI 0.15–0.45), food impaction (OR 0.26, 95% CI 0.11–0.55), stricture occurrence (OR 0.52 95% CI 0.29–0.92), and esophageal dilation (OR 0.29, 95% CI 0.15–0.54). Assessing MPR before repeating an esophagogastroduodenoscopy may decrease unnecessary procedures in the clinical management of eosinophilic esophagitis.

Keywords